atrasentan has been researched along with Cardiovascular Pregnancy Complications in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, W; Cockrell, K; Granger, JP; LaMarca, BB; Sullivan, E | 1 |
| Alexander, BT; Bennett, WA; Cockrell, KL; Granger, JP; Massey, MB; Rinewalt, AN | 1 |
2 other study(ies) available for atrasentan and Cardiovascular Pregnancy Complications
| Article | Year |
|---|---|
Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats.
Topics: Animals; Aorta; Atrasentan; Blood Pressure; Endothelin A Receptor Antagonists; Endothelin-1; Endothelins; Female; Hypertension; Kidney; Placenta; Pregnancy; Pregnancy Complications, Cardiovascular; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha | 2005 |
Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure.
Topics: Animals; Atrasentan; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Hypertension; Kidney Cortex; Kidney Medulla; Perfusion; Pregnancy; Pregnancy Complications, Cardiovascular; Protein Precursors; Pyrrolidines; Rats; Receptor, Endothelin A; RNA, Messenger; Uterus | 2001 |